Peters, Solange; Dafni, Urania; Boyer, Michael; De Ruysscher, Dirk; Faivre-Finn, Corinne; Felip, Enriqueta; Garrido, Pilar; Girard, Nicolas; Guckenberger, Matthias; Haanen, John; Le Pechoux, Cecile; Mornex, Francoise; Ozsahin, Mahmut; Paz-Ares, Luis; Planchard, David; Raben, David; Ramalingam, Suresh; Reck, Martin; Smit, Egbert; Stahel, Rolf; Stenzinger, Albrecht; Swanton, Charlie; Vallone, Stefania; Garassino, Marina (2019). Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III Non-Small Cell Lung Cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP). Annals of Oncology, 30(2):161-165.
Statistics
Citations
Altmetrics
Additional indexing
Item Type: | Journal Article, refereed, further contribution |
---|---|
Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Radiation Oncology
04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology and Hematology |
Dewey Decimal Classification: | 610 Medicine & health |
Language: | English |
Date: | 1 February 2019 |
Deposited On: | 12 Feb 2019 15:37 |
Last Modified: | 28 Oct 2019 08:06 |
Publisher: | Oxford University Press |
ISSN: | 0923-7534 |
OA Status: | Closed |
Free access at: | Publisher DOI. An embargo period may apply. |
Publisher DOI: | https://doi.org/10.1093/annonc/mdy553 |
PubMed ID: | 30624547 |
Download
Full text not available from this repository.
View at publisher
Get full-text in a library
- Google Plus
Article Networks
Author Collaborations























